Cyclic peptide drugs approved in the last two decades (2001–2021)
H Zhang, S Chen - RSC Chemical Biology, 2022 - pubs.rsc.org
In contrast to the major families of small molecules and antibodies, cyclic peptides, as a
family of synthesizable macromolecules, have distinct biochemical and therapeutic …
family of synthesizable macromolecules, have distinct biochemical and therapeutic …
Macrocyclization strategies for cyclic peptides and peptidomimetics
C Bechtler, C Lamers - RSC Medicinal Chemistry, 2021 - pubs.rsc.org
Peptides are a growing therapeutic class due to their unique spatial characteristics that can
target traditionally “undruggable” protein–protein interactions and surfaces. Despite their …
target traditionally “undruggable” protein–protein interactions and surfaces. Despite their …
An amide to thioamide substitution improves the permeability and bioavailability of macrocyclic peptides
Solvent shielding of the amide hydrogen bond donor (NH groups) through chemical
modification or conformational control has been successfully utilized to impart membrane …
modification or conformational control has been successfully utilized to impart membrane …
Rational design of peptide-based inhibitors disrupting protein-protein interactions
X Wang, D Ni, Y Liu, S Lu - Frontiers in chemistry, 2021 - frontiersin.org
Protein-protein interactions (PPIs) are well-established as a class of promising drug targets
for their implications in a wide range of biological processes. However, drug development …
for their implications in a wide range of biological processes. However, drug development …
Intelligent biomaterialomics: molecular design, manufacturing, and biomedical applications
Y Yi, HW An, H Wang - Advanced Materials, 2024 - Wiley Online Library
Materialomics integrates experiment, theory, and computation in a high‐throughput manner,
and has changed the paradigm for the research and development of new functional …
and has changed the paradigm for the research and development of new functional …
Overcoming the shortcomings of peptide-based therapeutics
C Lamers - Future Drug Discovery, 2022 - Taylor & Francis
Peptides have traditionally been perceived as poor drug candidates due to unfavorable
characteristics mainly regarding their pharmacokinetic behavior, including plasma stability …
characteristics mainly regarding their pharmacokinetic behavior, including plasma stability …
HAPPENN is a novel tool for hemolytic activity prediction for therapeutic peptides which employs neural networks
PB Timmons, CM Hewage - Scientific reports, 2020 - nature.com
The growing prevalence of resistance to antibiotics motivates the search for new
antibacterial agents. Antimicrobial peptides are a diverse class of well-studied membrane …
antibacterial agents. Antimicrobial peptides are a diverse class of well-studied membrane …
A single-molecule electrical approach for amino acid detection and chirality recognition
One of the ultimate goals of analytic chemistry is to efficiently discriminate between amino
acids. Here we demonstrate this ability using a single-molecule electrical methodology …
acids. Here we demonstrate this ability using a single-molecule electrical methodology …
Review of phage display: A jack-of-all-trades and master of most biomolecule display
Phage display was first described by George P. Smith when it was shown that virus particles
were capable of presenting foreign proteins on their surface. The technology has paved the …
were capable of presenting foreign proteins on their surface. The technology has paved the …
Selection of Nucleotide-Encoded Mass Libraries of Macrocyclic Peptides for Inaccessible Drug Targets
K Colas, D Bindl, H Suga - Chemical Reviews, 2024 - ACS Publications
Technological advances and breakthrough developments in the pharmaceutical field are
knocking at the door of the “undruggable” fortress with increasing insistence. Notably, the …
knocking at the door of the “undruggable” fortress with increasing insistence. Notably, the …